TC
HZNP

TwinBeech Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TwinBeech Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-97,333
Closed -$7.76M – 872
2022
Q2 		$7.76M Buy
97,333
+53,933
+124% +$5.11M 0.35% 84
2022
Q1 		$4.57M Buy
43,400
+29,979
+223% +$2.92M 0.2% 137
2021
Q4 		$1.45M Buy
+13,421
New +$1.46M 0.08% 279
2021
Q1 		– Sell
-47,383
Closed -$3.47M – 727
2020
Q4 		$3.47M Buy
47,383
+41,983
+777% +$3.12M 0.56% 44
2020
Q3 		$419K Buy
+5,400
New +$372K 0.09% 297
2020
Q2 		– Sell
-25,488
Closed -$755K – 532
2020
Q1 		$755K Buy
+25,488
New +$862K 0.3% 120

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return